Estrella Immunopharma Stock (NASDAQ:UPTD)


OwnershipFinancialsChart

Previous Close

$9.96

52W Range

$6.88 - $33.00

50D Avg

$10.12

200D Avg

$10.52

Market Cap

$20.25M

Avg Vol (3M)

$558.16K

Beta

0.12

Div Yield

-

UPTD Company Profile


TradeUP Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other business combination with one or more businesses. It intends to focus its search on companies in the technology industry. The company was incorporated in 2021 and is based in New York, New York.

Show More

Industry

Shell Companies

Sector

Financial Services

Exchange

NASDAQ

ADR

-

Country

US

Employees

-

IPO Date

Sep 14, 2021

Website

-

UPTD Performance


UPTD Financial Summary


Jun 24Dec 22Jun 22
Revenue---
Operating Income$-7.31M$-1.57M$-1.69M
Net Income$-7.31M$-996.10K$-1.69M
EBITDA$-7.31M$-1.57M$-1.69M
Basic EPS$-0.27$-0.17$-0.29
Diluted EPS$-0.27$-0.17$-0.29

Fiscal year ends in Jun 24 | Currency in USD

Peer Comparison


TickerCompany
DTOCAmerican Oncology Network, Inc.
PNACPrime Number Acquisition I Corp.
LGVCLAMF Global Ventures Corp. I
LBBBLakeshore Acquisition II Corp.
ITAQIndustrial Tech Acquisitions II, Inc.
FLFVFeutune Light Acquisition Corporation
BHACCrixus BH3 Acquisition Company
CPAAAdvantage Solutions Inc.
BLACBellevue Life Sciences Acquisition Corp.